myxomatous mitral valve disease of the dog Flashcards
1
Q
what is the epidemiology and prevalence
A
- 75-80% of canine cardiac diseases
- small breed dogs»_space; large breed dogs
- no sex predilection M=F
- synonyms: degenerative mitral valve disease, mitral valve disease, endocarditis
2
Q
what is the etiology
A
unknown
- collagen abnormality (collapsing trachea, IVDD, luxating patellas, cruciate ligament rupture)
- hereditay
- no proven infectious etiology
3
Q
what is the timing of MMVD murmer
A
systolic
4
Q
location of MMVD murmur
A
- left > right
- apical > basilar
5
Q
intensity of MMVD
A
- soft
- moderate
- loud
- thrilling
6
Q
what is a mitral murmur
A
- specific and sensitive for presence of disease
- variable as an indicator of severity of disease
7
Q
what are false positives with MMVD murmur
A
- common
- loud murmur, but mild disease
8
Q
what are false negatives with MMVD murmur
A
- uncommon
- soft murmur, but severe disease
9
Q
what are the key characteristics in assessing severity of MMVD
A
left atrial and ventricular size
10
Q
how to directly asses LA and LV size
A
- thoracic radiography
- echocardiography
11
Q
how to indirectly assess LA and LV size
less reliable
A
- murmur intensity
- ECG
- BNP concentration
12
Q
what do you see in an xray with MMVD
A
- LA, LV enlargement
- pulmonary venous distention
- perihilar interstitial/alveolar
13
Q
what do you see in an echo with MMVD
A
- thickened valve leaflets
- prolapse of leaflets into LA
- ruptured chordae tendineae
- color flow doppler reveals regurgitant flow into LA
14
Q
what are the MVD stages/classification system
A
- stage A: no disease, at risk (older small breed dog)
- stage B: MVD present, no current or historical clinical signs (asymptomatic, pre-clinical)
- stage B1: no cardiac enlargement
- stage B2: cardiac enlargement present
- stage C: MVD present, current or historical heart failure, conventional CHF
- stage D: MVD present, advanced disease, refractory clinical signs
15
Q
why stage asymptomatic (stage B) MVD?
A
- many dogs with mild MVD (B1) will never develop CHF (no reason to tx)
- dogs with secondary cardiac enlargement (B2) have greater risk for future CHF, which is reduced by oral pimobendan